Additionally, itaconate affects cellular antioxidant metabolic programs via the activation of the transcription factor nuclear factor, erythroid 2 like 2 (NRF2; also known as NFE2L2), again potentially altering cancer cell metabolism (Bambouskova et al., 2018; Mills et al., 2018). This evidence concerns the gene NFE2L2 and cancer.